Prostate Cancer Health Center
This article is from the WebMD News Archive
Fathers Get 16% More Prostate Cancer
Jan. 7, 2008 -- When a man fathers his first child, his lifetime risk of prostate cancer goes up 16%.
Nobody has any idea why this might be so, but the finding, based on 51.6 million man-years of data, is as certain as any statistical fact can be.
Here's another piece of the puzzle: After a man fathers a second child, each new child cuts his prostate cancer risk by 5%.
Why these things might happen is a mystery even to the researchers who discovered the disturbing factoids. But facts they are, says Morten Frisch, MD, PhD, DSc, senior investigator at the Statens Serum Institute in Copenhagen, Denmark.
"This is very, very, very statistically significant," Frisch tells WebMD. "It could be the one needle in the haystack; just a statistical anomaly. But we don't believe that. The findings are very comparable to a larger study in Sweden and also to other studies. I do not think you should attribute this to chance."
Why might fathering a child increase prostate cancer risk? Why should three or more children diminish this risk?
"This is very puzzling," Frisch says. "We have no good biological data to give us a hint as to why these two apparently divergent findings come up. Probably there are two different explanations."
Frisch and colleagues published their findings in the Feb. 15 issue of the American Cancer Society's journal Cancer. So WebMD asked ACS chief medical officer Otis Brawley, MD, to explain the findings.
"I still wonder about this finding itself," Brawley says. "Nobody can recommend that men not have kids to prevent having prostate cancer. It may be there is something about guys with good sperm motility having a higher risk of prostate cancer, although I don't believe that to be true."
The true importance of the finding, if any, may not become clear for years. Brawley points to the example of the 1930s finding that nuns rarely got cervical cancer -- and that many of the few nuns who did were reformed "bad girls."
Now, Brawley says, we know that cervical cancer can be caused by human papillomavirus, a sexually transmitted infection not yet linked to cancer in the 1930s.
Frisch notes that the study disproves an earlier finding that men who do not have sons are at increased risk of prostate cancer. The Danish data shows that the sex of a man's offspring does not affect his prostate cancer risk.
Indication
Uroxatral® (alfuzosin HCl 10 mg extended-release tablets) is an alpha1-blocker for the treatment of the signs and symptoms of BPH.
Important Safety Information
Do not take UROXATRAL if you have liver problems or if you are taking antifungal drugs like ketoconazole or itraconazole, or HIV drugs like ritonavir.
UROXATRAL can cause a sudden drop in blood pressure, especially when starting treatment. This may lead to fainting, dizziness, and lightheadedness. Do not drive, operate machinery, or do any dangerous activity until you know how UROXATRAL will affect you. This is especially important if you already have a problem with low blood pressure or take medicines to treat high blood pressure. There may be an increased risk of low blood pressure and fainting when taking UROXATRAL in combination with blood pressure medication or nitrates, or erectile dysfunction medication.
If considering cataract surgery (clouding of the eyes), tell your eye surgeon that you are currently taking UROXATRAL or have previously been treated with an alpha-blocker.
Before taking UROXATRAL, tell your doctor if you have kidney problems.
Also, tell your doctor if you or any family member(s) have or take medications for a rare heart condition known as congenital prolongation of the QT interval.
BPH and prostate cancer can cause the same symptoms. However, UROXATRAL is not a treatment for prostate cancer.
The most common side effects with UROXATRAL are dizziness, upper respiratory tract infection, headache, and tiredness.
Please see UROXATRAL full prescribing information.


